334 filings
Page 4 of 17
8-K
aqxc8 1txk
30 Mar 23
Amendments to Articles of Incorporation or Bylaws
12:31pm
8-K
syvu5i 52zu0mfxtskw
24 Mar 23
Submission of Matters to a Vote of Security Holders
4:44pm
D
tl0 qr5dd
1 Mar 23
$2.82 mm in options / securities to be acquired, sold $2.82 mm, 8 investors
10:33am
8-A12G/A
idsosweydph
8 Feb 23
Registration of securities (amended)
10:36am
8-K
d0ko30u
7 Feb 23
Ensysce Biosciences, Inc. Announces $3 Million Registered Direct Offering
5:14pm
424B5
l0yssdu17 e5
6 Feb 23
Prospectus supplement for primary offering
12:36pm
8-K
ezbjuxjomw 7l
1 Feb 23
Ensysce Biosciences Announces the Distribution of Series A Preferred Stock to Holders of its Common Stock
1:17pm
8-A12G
nuw2amnl5 ci
1 Feb 23
Registration of securities
11:55am
8-K
uh97t3xyaq7pf
30 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:19pm
8-K
auvxlhdx
18 Jan 23
Other Events
7:15pm
EFFECT
pjn y68db2f6mgpf5d
18 Jan 23
Notice of effectiveness
12:15am
8-K
36s78my
13 Jan 23
Entry into a Material Definitive Agreement
6:15am
CORRESP
bznrow shl6
13 Jan 23
Correspondence with SEC
12:00am
UPLOAD
79sx9roupwx3e8
13 Jan 23
Letter from SEC
12:00am
424B4
4ebu1c
3 Jan 23
Prospectus supplement with pricing info
11:52am